ArticleFrontiers in immunology2021

S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer.

Yuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.